|
| 37321843 | Predictors of starting and stopping chemsex in men who have sex with men in England: findings from the AURAH2 prospective study. | | 2023 |
| 37213438 | Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection. | NEJM Evid | 2023 |
| 37200312 | The military spouse experience of living alongside their serving/veteran partner with a mental health issue: A systematic review and narrative synthesis. | | 2023 |
| 34534138 | Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy - naive adults with HIV-1 infection. | AIDS | 2022 |
| 35848573 | Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens. | AIDS | 2022 |
| 35589352 | Qualitative study exploring the experiences and perceptions of dolutegravir/lamivudine dual antiretroviral therapy (the PEDAL study) in people living with HIV: protocol. | BMJ Open | 2022 |
| 36564186 | Self-start HIV postexposure prophylaxis (PEPSE), to reduce time to first dose and increase efficacy. | | 2022 |
| 35182281 | Perceptions and Practicalities Influencing Pre-exposure Prophylaxis Adherence Among Men Who Have Sex with Men in England. | AIDS and Behavior | 2022 |
| 34611495 | No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approach. | Journal of Virus Eradication | 2021 |
| 33964099 | Tolerability of four-drug antiretroviral combination therapy in primary HIV-1 infection. | HIV Medicine | 2021 |
| 34286237 | The epidemiology of kidney disease in people of African ancestry with HIV in the UK. | eClinicalMedicine | 2021 |
| 34143781 | Trends in HIV incidence between 2013-2019 and association of baseline factors with subsequent incident HIV among gay, bisexual, and other men who have sex with men attending sexual health clinics in England: A prospective cohort study. | PLoS Medicine | 2021 |
| 33079903 | Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European Study. | Journal of acquired immune deficiency syndromes (1999) | 2021 |
| 32888443 | Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study. | Lancet Public Health, The | 2020 |
| 32202510 | Genital secretion HIV RNA shedding in HIV-positive patients on ritonavir-boosted protease inhibitor monotherapy or standard combination ART: a cross-sectional sub-study from the PIVOT Trial. | Antiviral Therapy | 2020 |
| 32243033 | High incidence of Hepatitis C virus infection observed in the PROUD study of HIV pre-exposure prophylaxis. | Journal of Viral Hepatitis | 2020 |
| 31834000 | Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials. | J Acquir Immune Defic Syndr | 2020 |
| 32711800 | Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial. | Lancet, The | 2020 |
| 33067277 | Exploring and understanding the scope and value of the Parkinson's nurse in the UK (The USP Project): a realist economic evaluation protocol. | BMJ Open | 2020 |
| 32504574 | Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials. | Lancet HIV | 2020 |
| 30932951 | Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials. | AIDS | 2019 |
| 31826890 | Prevalence and correlates of depressive symptoms among gay, bisexual and other men who have sex with men in the PROUD randomised clinical trial of HIV pre-exposure prophylaxis. | BMJ Open | 2019 |
| 30306439 | The Context of Sexual Risk Behaviour Among Men Who Have Sex with Men Seeking PrEP, and the Impact of PrEP on Sexual Behaviour. | AIDS and Behavior | 2019 |
| 30420123 | Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials. | Lancet | 2019 |
| 30376108 | Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial. | Journal of Antimicrobial Chemotherapy | 2019 |
| 30084882 | Brain Perfusion, Regional Volumes, and Cognitive Function in Human Immunodeficiency Virus-positive Patients Treated With Protease Inhibitor Monotherapy. | Clinical Infectious Diseases | 2019 |
| 31303140 | Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials. | HIV Research and Clinical Practice | 2019 |
| 30816572 | A constructivist grounded theory study to explore compassion through the perceptions of individuals who have experienced nursing care. | Journal of Advanced Nursing | 2019 |
| 31023281 | Intimate partner violence, depression, and sexual behaviour among gay, bisexual and other men who have sex with men in the PROUD trial. | BMC Public Health | 2019 |
| 31068270 | Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial. | Lancet HIV | 2019 |
| 31335807 | Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe. | AIDS | 2019 |
| 29112060 | Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV? | AIDS | 2018 |
| 28703491 | Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study. | HIV Medicine | 2018 |
| 29956087 | Patient-Reported Symptoms Over 48Â Weeks Among Participants in Randomized, Double-Blind, Phase III Non-inferiority Trials of Adults with HIV on Co-formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide versus Co-formulated Abacavir, Dolutegravir, and Lamivudine. | Patient | 2018 |
| 29271606 | Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort. | HIV Med | 2018 |
| 29438199 | Changes in cerebral function parameters with maraviroc-intensified antiretroviral therapy in treatment naive HIV-positive individuals. | AIDS | 2018 |
| 29700052 | Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013-2016. | Sexually Transmitted Infections | 2018 |
| 27673443 | Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study. | J Acquir Immune Defic Syndr | 2017 |
| 28507772 | Clinically significant depressive symptoms and sexual behaviour among men who have sex with men. | BJPsych Open | 2017 |
| 28426834 | Acceptability of an open-label wait-listed trial design: Experiences from the PROUD PrEP study. | PLoS ONE | 2017 |
| 28851787 | A qualitative study exploring the social and environmental context of recently acquired HIV infection among men who have sex with men in South-East England. | BMJ Open | 2017 |
| 28668686 | Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trial. | International Journal of Antimicrobial Agents | 2017 |
| 28369381 | Randomized controlled trial of the tolerability and completion of maraviroc compared with Kaletra® in combination with Truvada® for HIV post-exposure prophylaxis (MiPEP Trial). | Journal of Antimicrobial Chemotherapy | 2017 |
| 28361642 | Nursing care for people with delirium superimposed on dementia. | Nursing older people | 2017 |
| 28272164 | Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults. | Journal of acquired immune deficiency syndromes (1999) | 2017 |
| 28282300 | Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results. | J Acquir Immune Defic Syndr | 2017 |
| 28234235 | Evaluation of cerebrospinal fluid virological escape in patients on long-term protease inhibitor monotherapy. | Antiviral Therapy | 2017 |
| 28189979 | Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics. | International Journal of Drug Policy | 2017 |
| 27773665 | Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial. | Lancet Respiratory Medicine,The | 2016 |
| 27143662 | Neurocognitive Function and Neuroimaging Markers in Virologically Suppressed HIV-positive Patients Randomized to Ritonavir-boosted Protease Inhibitor Monotherapy or Standard Combination ART: A Cross-sectional Substudy From the PIVOT Trial. | Clinical Infectious Diseases | 2016 |